DSM-Firmenich AG (DSFIR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, DSM-Firmenich AG (DSFIR) has a cash flow conversion efficiency ratio of 0.007x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€146.00 Million ≈ $170.69 Million USD) by net assets (€21.51 Billion ≈ $25.15 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See DSM-Firmenich AG (DSFIR) liquidity interval to measure how many days the company can operate on defensive assets alone.
DSM-Firmenich AG - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how DSM-Firmenich AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.
DSM-Firmenich AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of DSM-Firmenich AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
AIB Group PLC
IR:A5G
|
-0.057x |
|
COCA COLA HBC AG ADRS
F:CCKC
|
N/A |
|
Zhejiang Juhua Co Ltd
SHG:600160
|
0.039x |
|
EDP - Energias de Portugal S.A.
LS:EDP
|
0.038x |
|
Canon Inc
F:CNNA
|
0.044x |
|
Valterra Platinum Limited
JSE:VAL
|
0.264x |
|
Api Group Corp
NYSE:APG
|
0.024x |
|
Companhia de Saneamento Básico do Estado de São Paulo - SABESP
F:SAJA
|
0.021x |
Annual Cash Flow Conversion Efficiency for DSM-Firmenich AG (2013–2025)
The table below shows the annual cash flow conversion efficiency of DSM-Firmenich AG from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see DSFIR company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €18.42 Billion ≈ $21.54 Billion |
€1.39 Billion ≈ $1.62 Billion |
0.075x | -3.82% |
| 2024-12-31 | €22.70 Billion ≈ $26.54 Billion |
€1.78 Billion ≈ $2.08 Billion |
0.078x | +42.86% |
| 2023-12-31 | €23.07 Billion ≈ $26.97 Billion |
€1.26 Billion ≈ $1.48 Billion |
0.055x | -35.57% |
| 2022-12-31 | €10.85 Billion ≈ $12.68 Billion |
€923.00 Million ≈ $1.08 Billion |
0.085x | -43.95% |
| 2021-12-31 | €9.40 Billion ≈ $10.99 Billion |
€1.43 Billion ≈ $1.67 Billion |
0.152x | -23.90% |
| 2020-12-31 | €7.49 Billion ≈ $8.75 Billion |
€1.49 Billion ≈ $1.75 Billion |
0.200x | +12.88% |
| 2019-12-31 | €7.83 Billion ≈ $9.16 Billion |
€1.39 Billion ≈ $1.62 Billion |
0.177x | -0.69% |
| 2018-12-31 | €7.82 Billion ≈ $9.14 Billion |
€1.39 Billion ≈ $1.63 Billion |
0.178x | +26.26% |
| 2017-12-31 | €7.07 Billion ≈ $8.26 Billion |
€996.00 Million ≈ $1.16 Billion |
0.141x | -14.42% |
| 2016-12-31 | €6.18 Billion ≈ $7.23 Billion |
€1.02 Billion ≈ $1.19 Billion |
0.165x | +33.27% |
| 2015-12-31 | €5.63 Billion ≈ $6.58 Billion |
€696.00 Million ≈ $813.70 Million |
0.124x | -9.20% |
| 2014-12-31 | €5.94 Billion ≈ $6.94 Billion |
€808.00 Million ≈ $944.64 Million |
0.136x | -16.86% |
| 2013-12-31 | €6.10 Billion ≈ $7.13 Billion |
€998.00 Million ≈ $1.17 Billion |
0.164x | -- |
About DSM-Firmenich AG
DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, sy… Read more